Clinical Trial Update: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of a Bruton's Tyrosine Kinase inhibitor in subjects with chronic graft-versus-host disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Bruton's Tyrosine Kinase inhibitor

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-11